Professional Documents
Culture Documents
The Peruvian
Experience
Author(s): B. Chomel, G. Chappuis, F. Bullon, E. Cardenas, T. David de Beublain, M. Lombard
and E. Giambruno
Source: Reviews of Infectious Diseases, Vol. 10, Supplement 4. Research towards Rabies
Prevention (Nov. - Dec., 1988), pp. S697-S702
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4454721 .
Accessed: 24/01/2015 22:05
Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at .
http://www.jstor.org/page/info/about/policies/terms.jsp
.
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of
content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms
of scholarship. For more information about JSTOR, please contact support@jstor.org.
Oxford University Press is collaborating with JSTOR to digitize, preserve and extend access to Reviews of
Infectious Diseases.
http://www.jstor.org
In a mass vaccination campaign conducted in Peru in March 1985, 270,000 dogs (65%
of the estimated dog population) were vaccinated over the course of 1 month with an
inactivatedtissue culturevaccine.Since that time no human rabiescases have been reported;
in addition, the number of animal rabies cases has declined to only three from a previous
mean of 292 cases per year since 1980. A serologic survey was also done to determine
the immune response among randomly selected vaccinated dogs, with titers determined
3, 6, 9, and 12 months after vaccination. Twelvemonths after vaccination, 97% of the
dogs had a rabies neutralizing antibody titer of >0.5 IU/mL, and 87% had a titer of >1.0
IU/mL. Thus, this tissue culture rabies vaccine given under field conditions induced anti-
bodies that lasted for at least 1 year in 97%oof vaccinated dogs.
S697
1200 -
Table 1. Number of rabies cases reported in Peru, by
species, 1980-1985. 1000 -
878 98 976 9
0
a
400- A -10
1980
1981 1,406 134 1,540 29 200 cat
1982 1,893 183 2,076 39
118 31 ...0 0
1983 1,149 1,267 1970 1972 1974 1976 1978 1980 1982 1984
1
1986
1984 840 156 996 32
YEAR
1985 505 NA NA 28
Figure 1. Reportedrabiescases,byyear,in Lima-Callao,
NOTE. Source: Peruvian Ministry of Health. NA = data Peru (January1970through1 October1986).
not available.
overseeing the campaign in one of the 11 sectors of surveywas conducted by PAHO, the PeruvianMinis-
Lima-Callao. try of Health, and Mission Bioforce [9]. Fifteen dis-
Each day from 25 Februaryto 27 March, the 110 tricts of Lima-Callao were randomly selected, with
teams began work at vaccination sites at 8 A.M.The exclusion of the high socioeconomic districts.Blocks
supervisors, in cars with loudspeakers, urged peo- wererandomly selected within each surveyeddistrict
ple to bring their animals in for vaccination. That according to the population size. In turn, 10 house-
appeal was augmented by students on summer va- holds in each of these blocks were selected by a clus-
cation. Each vaccinated animal had a blue collar ter technique (95% confidence level, 1%0precision).
placed on it, and the owner was given a vaccination The data gathered included the number of per-
certificate. The recorder registeredthe species, sex, sons, dogs, and cats per household; the sex of all
age, and vaccination status (primary or booster in- animals; the history of animal vaccination; and the
jection) of the animal. number of animals with a blue collar. At the begin-
Through international cooperative efforts, Peru ning, the number of vaccinations performed by pri-
was given 600 doses of newly licensed human vac- vate veterinarians in Lima-Callao was estimated.
cine produced on Vero cells by the Institut Merieux This number was added to the number of vaccina-
in Lyon, France, and approved by the World Health tions performed at the Antirabies Center and the
Organization (WHO). This vaccine was used for numberperformedduringthe mass campaignto give
preexposure vaccination of the vaccinators. In ad- the overall vaccination coverage.
dition, Peru received 500,000 doses of animal vac-
cine (Rabisin, Rhone-Merieux, Lyon). This vaccine
was produced with the Pasteur PV 11 strain on a SerologicStudy and 12-MonthSurvey:I
hamster embryonic cell line and was inactivated by A survey was conducted to obtain information on
P-propiolactone; the adjuvant used was aluminum a representative sample of vaccinated dogs from
hydroxide. A 1.0-mL dose was administered sub- which serum specimens were collected 3, 6, 9, and
cutaneously to dogs. The latter vaccine has been 12 months after the March 1985campaign. For each
shown to be immunogenic, safe, and stable and to collection period, a different sample was chosen.
provide immunity against rabies for 3 years [8]. Twentydistricts of the city and a block within each
Other supplies furnished by health agencies con- district were randomly selected. In each block, ev-
sisted of 50,000 syringes, 75,000 needles, 160 insu- ery 10th house was visited. After verification of the
lated boxes and ice packs, 500,000 vaccination cer- vaccination certificate,blood was obtained from one
tificates, and 500,000 blue collars to be placed on household dog. A total of 10 dogs per district were
vaccinated animals. sampled. Only dogs vaccinatedduring the campaign
One month after the completion of the vaccina- were included. When severaldogs were found in the
tion campaign (April 1985), a follow-up survey was same household, only one of those vaccinated for
carried out to evaluate the ratio of dogs and cats to the first time in March 1985 was randomly selected.
humans and the number of animals vaccinated.This Appropriate sample sizes were calculated for an
Table 3. Dog sample characteristics (sex, age, and vaccination status): Lima-Callao, Peru, 1985-1986.
Sex (%) Age (%) Vaccination status (%)
Time after No. of
vaccine (mo) dogs Male Female <1 y >1 y Primary Booster
3 137 60 40 35 65 53 47
6 151 59 41 37 63 67 33
9 130 63 37 28 72 39 61
12 198 74 26 0 100 90 10
The impact of the vaccination campaign on ani- dogs werecounted in these 200 households; i.e., there
mal and human rabies is shown in figure 2. After were 1.5 dogs per household. Since 23 (8%) of the
March 1985 the number of rabies cases in dogs dogs were acquired after March 1985, 281 (92%) of
dropped dramatically; in fact, after May 1985 only them were already living in these households in
one such case was reported (in December 1985, in March 1985. However, it was reported that 35 dogs
a young puppy not vaccinatedin March).Threecases had either died or disappeared since March 1985.
were observed in cats: one in November 1985, one Therefore, 316 dogs (281+ 35) were living in the 200
in December 1985, and one (an imported case) in households in March 1985, and 11%0 had either died
1987. No other cases in dogs or cats have been or disappeared within a year.
reported to date. No cases in humans have been Fewer than 50% of dogs had blue collars, but
reported since March 1985; in contrast, there were owners produced vaccination certificates for 95?%o
eight reporteddeaths in 1983, five in 1984, and three (267 of 281). One hundred seventy-three (87%) of
in the first quarter of 1985. the dogs sampled 12 months after the campaignlived
in the same district where they were born, but 75%o
regularly roamed the streets.
SerologicStudyand 12-MonthSurvey:II
Serologic results are summarized in tables 4 and
The size of the differentdog samplesand the animals' 5. Dogs vaccinated 1 year previously had a mean an-
sex, age, and vaccination status are summarized in tibody titer of 4.33 IU/mL (table 4, figure 3), with
table 3. Blood samples were obtained from 137 dogs 97%oof these titers >0.5 IU/mL (figure3). Therewas,
3 months after vaccination, from 151 dogs after 6 however, a steady decrease in antibody titers: 64%
months, from 130 dogs after 9 months, and from of dogs had >5.0 IU/mL after 3 months (mean,
198 dogs after 12 months. (In fact, samples were ob- 11.13IU/mL), whereasonly 46% had levels this high
tained from 200 dogs after 12 months but an insuffi- after 6 months (mean, 7.96 IU/mL), 29%oafter 9
cient volume of serum was collected for testing from months (mean, 5.02 IU/mL), and 40%7after 12
two of these dogs.) Of the 198 dogs sampled after months (mean, 4.33 IU/mL) (figure 3). However,
12 months, 178 (90%) had been vaccinated for the >95% of dogs still had titers of >0.5 IU/mL after
first time during the March 1985 campaign. 12 months. There was no statistically significant
Two hundred households were visited during the
12-monthsurveyin March 1986. Three hundredfour
Table 5. Rabiesantibodytitersin dogs, by time after
vaccination:Lima-Callao,Peru, 1985-1986.
Table 4. Mean rabies antibody titers and kinetics: No. (%) of dogs with indicated
Lima-Callao,Peru, 1985-1986. titer (IU/mL)*
Time after No. <50
Antibody titer
Time after No.0 (IU/mL vaccination of
vaccination of (mo) dogs <0.5 <1.0 Total >5.0
(mo) dogs Mean CI Mean CI
3 137 2 (1.5) 11 (8) 50 (37) 87 (64)
2-3 137 1.95 1.86-2.04 11.13 8.79-13.47 6 151 4 (2.6) 23 (15) 81 (54) 70 (46)
6 151 1.60 1.53-1.67 7.96 5.96-9.96 9 130 7 (5.4) 29 (22) 92 (71) 38 (29)
9 130 1.52 1.43-1.60 5.02 3.38-6.66 12 198 6 (3) 26 (13) 119 (60) 79 (40)
12 198 1.61 1.54-1.69 4.33 2.53-6.13
* The protective threshold accepted by the World Health Or-
NOTE. CI = 95% confidence interval. ganization is 0.5 IU/mL.